Literature DB >> 17935232

Complete sex reversal in a WAGR syndrome patient.

Cedric Le Caignec1, Capucine Delnatte, Joris R Vermeesch, Michelle Boceno, Madeleine Joubert, Francoise Lavenant, Albert David, Jean-Marie Rival.   

Abstract

The WAGR contiguous gene deletion syndrome is a combination of Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation. Children with WAGR syndrome invariably have a constitutional chromosomal deletion at 11p13. WT1 haploinsufficiency is associated with a significant risk of Wilms tumor while PAX6 haploinsufficiency lead to aniridia, both genes located in the deleted region. The 46,XY patients with WAGR syndrome are often born with genital abnormalities such as cryptorchidism or hypospadias but more rarely ambiguous genitalia. To our knowledge, complete sex reversal has never been observed in WAGR syndrome patients. Here, we report on the clinical, cytogenetic, and molecular characterization of a child with WAGR syndrome and complete sex reversal. The young girl had female external and internal genitalia with normal uterus and fallopian tubes while the ovaries were not observed. Chromosomal analysis showed a 46,XY,del(11)(p12p14.1) karyotype. A 1-Mb resolution array CGH experiment estimated the size of the interstitial deletion at approximately 10 Mb encompassing WT1 and PAX6. The entire coding regions of WT1 and SRY have been sequenced and no mutation has been identified. Frasier syndrome (FS) and Denys-Drash syndrome (DDS) are two disorders associated with mutations in the WT1 gene. Complete sex reversal is a feature usually present in FS and sometimes in DDS, but until now never observed in WAGR syndrome. The present report suggests that these conditions may be considered as part of the spectrum of disease due to WT1 gene alterations. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935232     DOI: 10.1002/ajmg.a.31997

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

Review 2.  Aniridia.

Authors:  Melanie Hingorani; Isabel Hanson; Veronica van Heyningen
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

3.  Results From the WAGR Syndrome Patient Registry: Characterization of WAGR Spectrum and Recommendations for Care Management.

Authors:  Kelly A Duffy; Kelly L Trout; Jennifer M Gunckle; Shari McCullen Krantz; John Morris; Jennifer M Kalish
Journal:  Front Pediatr       Date:  2021-12-14       Impact factor: 3.418

4.  Characterization of Associated Nonclassical Phenotypes in Patients with Deletion in the WAGR Region Identified by Chromosomal Microarray: New Insights and Literature Review.

Authors:  Vanessa Sodré de Souza; Gabriela Corassa Rodrigues da Cunha; Beatriz R Versiani; Claudiner Pereira de Oliveira; Maria Teresa Alves Silva Rosa; Silviene F de Oliveira; Patricia N Moretti; Juliana F Mazzeu; Aline Pic-Taylor
Journal:  Mol Syndromol       Date:  2022-02-11

Review 5.  Molecular mechanisms of external genitalia development.

Authors:  Sarah D Blaschko; Gerald R Cunha; Laurence S Baskin
Journal:  Differentiation       Date:  2012-07-11       Impact factor: 3.880

Review 6.  New technologies for the identification of novel genetic markers of disorders of sex development (DSD).

Authors:  A Bashamboo; S Ledig; P Wieacker; J C Achermann; J Achermann; K McElreavey
Journal:  Sex Dev       Date:  2010-07-03       Impact factor: 1.824

Review 7.  Mammalian sex determination—insights from humans and mice.

Authors:  Stefanie Eggers; Andrew Sinclair
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

8.  Submicroscopic copy-number variations associated with 46,XY disorders of sex development.

Authors:  Masafumi Kon; Maki Fukami
Journal:  Mol Cell Pediatr       Date:  2015-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.